Ayahuasca, Esketamine and PTSD
NCT07317206 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2026-01-05
Summary
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Conditions
- Posttraumatic Stress Disorder (PTSD)
Interventions
- DRUG
-
Ayahuasca
oral ayahuasca
- DRUG
-
oral esketamine
Sponsors & Collaborators
-
University of Sao Paulo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-20
- Primary Completion
- 2026-06-30
- Completion
- 2026-07-31
Countries
- Brazil
Study Locations
More Related Trials
-
Ketamine Therapy Experiential Education Study
NCT05468047 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel
NCT00402298 ·Status: TERMINATED ·Phase: PHASE2
-
Molecular Imaging Study of Harmine/DMT: a Basic Research Approach
NCT06252506 ·Status: COMPLETED ·Phase: PHASE1
-
Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users
NCT02682225 ·Status: COMPLETED ·Phase: PHASE1
-
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
NCT01458327 ·Status: COMPLETED ·Phase: PHASE2
-
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
NCT00353938 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants
NCT02228239 ·Status: COMPLETED ·Phase: PHASE1
-
Psychedelic Therapy for Wellness Studies Retrospectively
NCT05469243 ·Status: UNKNOWN
-
Safety and Tolerability of DMT in Healthy Adults
NCT05901012 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants
NCT03808259 ·Status: COMPLETED ·Phase: PHASE1
-
MDMA for AUD/PTSD Comorbidity
NCT05943665 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Stimulant Drugs on Social Perception
NCT03790618 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
NCT05695495 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants
NCT02737605 ·Status: COMPLETED ·Phase: PHASE1
-
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
NCT06624137 ·Status: RECRUITING
-
Comparative Acute Effects of LSD, Psilocybin and Mescaline
NCT04227756 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants
NCT06180759 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Psychedelic Effects in Psychoactive Substances
NCT06772753 ·Status: RECRUITING ·Phase: PHASE1
-
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
NCT05709353 ·Status: RECRUITING ·Phase: PHASE2
-
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
NCT06884514 ·Status: RECRUITING ·Phase: PHASE1
-
Influence of Bupropion on the Effects of MDMA
NCT01771874 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Ketamine and Psychological Sequelae
NCT04053400 ·Status: COMPLETED
-
Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects
NCT04173962 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
NCT03752918 ·Status: WITHDRAWN ·Phase: PHASE1